tiprankstipranks
Lytix Biopharma AS (DE:6BG)
FRANKFURT:6BG
Germany Market

Lytix Biopharma AS (6BG) Financial Statements

0 Followers

Lytix Biopharma AS Financial Overview

Lytix Biopharma AS's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Lytix Biopharma AS is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenuekr 0.00kr 1.41Mkr 0.00kr 0.00kr 0.00
Gross Profit-----
EBITkr -14.09Mkr -17.94Mkr -9.99Mkr -14.67Mkr -16.40M
EBITDAkr -14.08Mkr -17.93Mkr -9.98Mkr -14.67Mkr -16.40M
Net Income Common Stockholderskr -29.19Mkr -11.15Mkr -1.18Mkr -15.23Mkr -16.39M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 145.16Mkr 171.58Mkr 177.08Mkr 180.67Mkr 197.28M
Total Assetskr 152.02Mkr 177.37Mkr 184.11Mkr 187.94Mkr 202.96M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -145.16Mkr -171.58Mkr -177.08Mkr -180.67Mkr -197.28M
Total Liabilitieskr 16.89Mkr 13.49Mkr 10.14Mkr 13.13Mkr 13.34M
Stockholders Equitykr 135.13Mkr 163.88Mkr 173.97Mkr 174.81Mkr 189.62M
Cash Flow-
Free Cash Flowkr -26.42Mkr -5.50Mkr -3.58Mkr -16.75Mkr -11.90M
Operating Cash Flowkr -26.42Mkr -5.49Mkr -3.48Mkr -16.71Mkr -11.90M
Investing Cash Flowkr -698.00Kkr -49.93Mkr -102.00Kkr -35.00K-
Financing Cash Flowkr 0.00kr 0.00kr 0.00kr 133.00Kkr 0.00
Currency in NOK

Lytix Biopharma AS Earnings and Revenue History

Lytix Biopharma AS Debt to Assets

Lytix Biopharma AS Cash Flow

Lytix Biopharma AS Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis